top of page

Pain

An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease

Medicinal cannabis in the treatment of chronic pain

Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review

Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy

Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint

Cannabinoid–Opioid Interaction in Chronic Pain

Cannabinoid receptors and pain

Cannabinoids delivery systems based on supramolecular inclusion complexes and polymeric nanocapsules for treatment of neuropathic pain

Cannabinoids for Neuropathic Pain

Cannabinoids for treatment of chronic non-cancer pain; a systematic review of
randomized trials

Cannabinoids in the management of difficult to treat pain

Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors

Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS)

Clinical implications for cannabinoid use in the rheumatic diseases: potential for help or harm?

Combined treatment with morphine and Δ9 -tetrahydrocannibinol (THC) in rhesus 
monkeys: antinociceptive tolerance and withdrawal

Injury, Pain, and Prescription Opioid Use Among Former National Football League (NFL) Players

Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol

Prescribing cannabis for harm reduction

Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes

 Role of Cannabinoids in Pain Management

Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ9-tetrahydrocannabinol in the rat

Smoked cannabis for chronic neuropathic pain: a randomized controlled trial

Stable dose cannabinoid medicine (Sativex®, THC+CBD) can provide sustained efficacy in the treatment of refractory painful diabetic neuropathy or other peripheral neuropathic pain associated with allodynia.

Survey Results of Pain Treatments in Adults with Cerebral Palsy

Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain

The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects

The Endocannabinoid System, Cannabinoids, and Pain

The endogenous cannabinoid system and its role in nociceptive behavior

The Pharmacologic and Clinical Effects of Medical Cannabis

Therapeutic Benefits of Cannabis: A Patient Survey

Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use

δ-Ctenitoxin-Pn1a, a Peptide from Phoneutria nigriventer Spider Venom, Shows Antinociceptive Effect Involving Opioid and Cannabinoid Systems, in Rats

Parkinson's Disease

Cannabidiol can improve complex sleep-related behaviours associated with rapid
eye movement sleep behaviour disorder in Parkinson’s disease patients: a case
series

Cannabidiol for the treatment of psychosis in Parkinson’s disease

Effects of cannabidiol in the treatment of patients with Parkinson’s disease:  An exploratory double-blind trial

GPR55: A therapeutic target for Parkinson's disease?

Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to
neuroprotection

Self-­Reported Efficacy of Cannabis and Other Complementary Medicine Modalities
by Parkinson's Disease Patients in Colorado

Survey on Cannabis Use in Parkinson’s Disease: Subjective Improvement of Motor Symptoms

The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats

The influence of cannabinoids on generic traits of neurodegeneration

Pregnancy

A Longitudinal Study of Prenatal Marijuana Use

Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines

Cannabis and Breastfeeding

Endocannabinoid System in First Trimester Placenta: Low FAAH and High CB1
Expression Characterize Spontaneous Miscarriage

Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling 

Five-year follow-up of rural Jamaican children whose mothers used marijuana during pregnancy

Identifying Prenatal Cannabis Exposure and Effects of Concurrent Tobacco Exposure on Neonatal Growth

Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain

Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation

Maternal Marijuana Use During Lactation and Infant Development at One Year

Multiple Roles for the Endocannabinoid System During the Earliest Stages of Life: Pre- and Postnatal Development

Prenatal Marijuana Exposure and Neonatal Outcomes in Jamaica: An Ethnographic Study

The Endocannabinoid-CB Receptor System: Importance for development and in pediatric disease

Transfer of Inhaled Cannabis Into Human Breast Milk

Prostate Cancer

Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest

Cannabinoid receptor as a novel target for the treatment of prostate cancer

Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines

Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2

Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms

Proapoptotic effect of endocannabinoids in prostate cancer cells

The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications

Psychedelic Therapy

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers.

A potential role for psilocybin in the treatment of obsessive-compulsive disorder. 

Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment.

Beckley Foundation for research into cannabis & psychedelics.

Classical psychedelics for the treatment of depression and anxiety: A systematic review.

LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model.

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.

Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.

Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.

Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis.

Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression.

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.​

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.​

Psychedelics and Psychedelic-Assisted Psychotherapy.​

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.

Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights from Psychedelic Medicine and Animal Models.

Reviewing the Potential of Psychedelics for the Treatment of PTSD.​

Spontaneous and deliberate creative cognition during and after psilocybin exposure.​

The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories.​

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.​

​Trial of Psilocybin versus Escitalopram for Depression.

Pulmonary Function

Association Between Marijuana Exposure and Pulmonary Function Over 20 Years

Bronchodilator Effect Of Delta1-Tetrahydrocannabinol

Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety

Does smoking marijuana increase the risk of chronic obstructive pulmonary disease?

Effects of Marijuana Smoking on the Lung

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma

Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation

Marijuana and chronic obstructive lung disease: a population-based study

Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice

Preclinical Assessment of Novel Therapeutics on the Cough Reflex: Cannabinoid Agonists as Potential Antitussives

The Effects of Marijuana Exposure on Expiratory Airflow A Study of Adults who Participated in the U.S. National Health and Nutrition Examination Study

bottom of page